Optimizing management of chronic pulmonary hypertension in preterm infants: strategies for a complex population

Carolina Michel-Macías1,2, Audrey Hébert3, Gabriel Altit2

  • 1Universidad Autónoma de Querétaro, Facultad de Medicina, Querérato, Mexico.

PubMed

Insights

Managing pulmonary hypertension in premature infants with bronchopulmonary dysplasia is crucial. Early intervention with ventilatory support, diuretics, and vasodilators, guided by echocardiography, improves outcomes and reduces mortality.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Pulmonary Medicine

Background:

  • Pulmonary hypertension (PH) is a significant complication in premature infants with bronchopulmonary dysplasia (BPD).
  • BPD-PH is linked to adverse outcomes and increased mortality in this vulnerable population.
  • The condition involves complex pulmonary vasculature changes with potential arterial and postcapillary components.

Purpose of the Study:

  • To review the current management strategies for pulmonary hypertension in infants with bronchopulmonary dysplasia.
  • To explore the heterogeneous effects and potential arterial and postcapillary involvement in BPD-PH.
  • To highlight the role of diagnostic tools and therapeutic interventions in managing BPD-PH.

Main Methods:

  • Review of current literature and observational studies on BPD-PH management.
  • Focus on optimizing ventilatory support and treating underlying lung disease.
  • Utilizing echocardiography for diagnosis, treatment guidance, and monitoring disease progression.

Main Results:

  • Optimizing ventilatory support and treating the underlying lung disease are foundational.
  • Diuretics are recommended for initial management, especially with right ventricular dilation.
  • Pulmonary vasodilator therapy is often necessary to reduce right ventricular strain and prevent cardiac complications.
  • Echocardiography is essential for guiding treatment decisions and monitoring BPD-PH.

Conclusions:

  • BPD-PH significantly increases mortality risk and long-term cardio-respiratory morbidity.
  • Echocardiography is valuable for screening, with catheterization for complex cases.
  • Effective BPD-PH management necessitates a multidisciplinary approach focusing on BPD treatment and underlying pathologies.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.8K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
195
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
167
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K